$CLDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Celldex Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Celldex Therapeutics, Inc.. Get notifications about new insider transactions in Celldex Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 25.41 | 92,000 | 2,337,720 | 92,000 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 25.41 | 92,000 | 2,337,720 | 92,000 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Executive VP & CMO | Option Exercise | A | 25.41 | 116,500 | 2,960,265 | 116,500 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Executive VP & CSO | Option Exercise | A | 25.41 | 116,500 | 2,960,265 | 116,500 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 25.41 | 280,000 | 7,114,800 | 280,000 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Grant | A | 0.00 | 6,500 | 0 | 8,500 | 2 K to 8.5 K (+325.00 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Elston George | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 6,500 | 0 | 18,500 | 12 K to 18.5 K (+54.17 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 6,500 | 0 | 18,500 | 12 K to 18.5 K (+54.17 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 6,500 | 0 | 21,833 | 15.3 K to 21.8 K (+42.39 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 6,500 | 0 | 21,916 | 15.4 K to 21.9 K (+42.16 %) |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 25.41 | 10,300 | 261,723 | 10,300 | |
| Jun 11 2015 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 6,500 | 0 | 33,500 | 27 K to 33.5 K (+24.07 %) |
| Dec 19 2014 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Option Exercise | A | 18.11 | 8,000 | 144,880 | 8,000 | |
| Dec 19 2014 | AVAN | Celldex Therapeuti ... | van den Broek Richard | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 09 2014 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 4.50 | 10,000 | 45,000 | 17,847 | |
| Sep 09 2014 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 4.50 | 10,000 | 45,000 | 24,609 | 14.6 K to 24.6 K (+68.45 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 83,212 | 81.2 K to 83.2 K (+2.46 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 12,000 | 10 K to 12 K (+20.00 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | Elston George | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 12,000 | 10 K to 12 K (+20.00 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 15,333 | 13.3 K to 15.3 K (+15.00 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 15,416 | 13.4 K to 15.4 K (+14.91 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 13.45 | 2,000 | 26,900 | 2,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 27,000 | 25 K to 27 K (+8.00 %) |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 13.45 | 92,000 | 1,237,400 | 92,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 13.45 | 92,000 | 1,237,400 | 92,000 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Option Exercise | A | 13.45 | 116,500 | 1,566,925 | 116,500 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Option Exercise | A | 13.45 | 116,500 | 1,566,925 | 116,500 | |
| Jun 05 2014 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 13.45 | 280,000 | 3,766,000 | 280,000 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | M | 8.16 | 17,728 | 144,660 | 0 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Sell | S | 24.50 | 17,728 | 434,336 | 13,333 | 31.1 K to 13.3 K (-57.07 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Buy | M | 8.16 | 17,728 | 144,660 | 31,061 | 13.3 K to 31.1 K (+132.96 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | M | 8.16 | 17,728 | 144,660 | 0 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Sell | S | 24.50 | 17,728 | 434,336 | 13,416 | 31.1 K to 13.4 K (-56.92 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Buy | M | 8.16 | 17,728 | 144,660 | 31,144 | 13.4 K to 31.1 K (+132.14 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | M | 8.16 | 17,728 | 144,660 | 0 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Sell | S | 24.50 | 17,728 | 434,336 | 25,000 | 42.7 K to 25 K (-41.49 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | M | 8.16 | 17,728 | 144,660 | 42,728 | 25 K to 42.7 K (+70.91 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.16 | 134,317 | 1,096,027 | 0 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | M | 8.16 | 49,016 | 399,971 | 134,317 | |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Sell | S | 24.50 | 183,333 | 4,491,659 | 14,109 | 197.4 K to 14.1 K (-92.85 %) |
| Dec 10 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | M | 8.16 | 183,333 | 1,495,997 | 197,442 | 14.1 K to 197.4 K (+1,299.40 %) |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 16.36 | 90,000 | 1,472,400 | 90,000 | |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | L | 5.95 | 500 | 2,975 | 14,109 | 13.6 K to 14.1 K (+3.67 %) |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 16.36 | 90,000 | 1,472,400 | 90,000 | |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Option Exercise | A | 16.36 | 115,000 | 1,881,400 | 115,000 | |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Option Exercise | A | 16.36 | 115,000 | 1,881,400 | 115,000 | |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 16.36 | 280,000 | 4,580,800 | 280,000 | |
| Jul 03 2013 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | L | 5.95 | 500 | 2,975 | 43,368 | 42.9 K to 43.4 K (+1.17 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 81,212 | 79.2 K to 81.2 K (+2.52 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | Elston George | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 10,000 | 8 K to 10 K (+25.00 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 10,000 | 8 K to 10 K (+25.00 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 13,333 | 11.3 K to 13.3 K (+17.65 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 13,416 | 11.4 K to 13.4 K (+17.52 %) |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Option Exercise | A | 15.20 | 2,000 | 30,400 | 2,000 | |
| Jun 20 2013 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 25,000 | 23 K to 25 K (+8.70 %) |
| Sep 13 2012 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 5.69 | 90,000 | 512,100 | 90,000 | |
| Sep 13 2012 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 5.69 | 90,000 | 512,100 | 90,000 | |
| Sep 13 2012 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Option Exercise | A | 5.69 | 115,000 | 654,350 | 115,000 | |
| Sep 13 2012 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Option Exercise | A | 5.69 | 115,000 | 654,350 | 115,000 | |
| Sep 13 2012 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 5.69 | 280,000 | 1,593,200 | 280,000 | |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 11,416 | 9.4 K to 11.4 K (+21.24 %) |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 11,333 | 9.3 K to 11.3 K (+21.43 %) |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 23,000 | 21 K to 23 K (+9.52 %) |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 8,000 | 6 K to 8 K (+33.33 %) |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 8,000 | 6 K to 8 K (+33.33 %) |
| Jun 21 2012 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 79,212 | 77.2 K to 79.2 K (+2.59 %) |
| Aug 11 2011 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Buy | P | 2.50 | 5,000 | 12,520 | 15,868 | 10.9 K to 15.9 K (+46.01 %) |
| Aug 10 2011 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 2.44 | 5,000 | 12,185 | 5,000 | 0 to 5 K |
| Aug 10 2011 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 2.42 | 5,000 | 12,100 | 5,000 | 0 to 5 K |
| Aug 10 2011 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 2.38 | 5,000 | 11,875 | 5,000 | 0 to 5 K |
| Aug 10 2011 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 2.39 | 2,000 | 4,780 | 2,000 | 0 to 2 K |
| Aug 08 2011 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Option Exercise | A | 2.80 | 104,500 | 292,600 | 104,500 | |
| Aug 08 2011 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 2.80 | 80,000 | 224,000 | 80,000 | |
| Aug 08 2011 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 2.80 | 180,400 | 505,120 | 180,400 | |
| Aug 08 2011 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Option Exercise | A | 2.80 | 99,000 | 277,200 | 99,000 | |
| Jul 06 2011 | AVAN | Celldex Therapeuti ... | PEPIN RONALD | Sr. VP & CBO | Option Exercise | A | 3.52 | 100,000 | 352,000 | 100,000 | |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jun 23 2011 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | PAREKH RAJESH R | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 22 2010 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Sep 16 2010 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Buy | P | 3.74 | 3,000 | 11,220 | 3,000 | 0 to 3 K |
| Sep 17 2010 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Buy | P | 3.78 | 1,011 | 3,822 | 1,011 | 0 to 1 K |
| Sep 17 2010 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Buy | P | 3.77 | 1,489 | 5,614 | 1,489 | 0 to 1.5 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Buy | P | 3.52 | 5,000 | 17,600 | 5,000 | 0 to 5 K |
| Sep 14 2010 | AVAN | Celldex Therapeuti ... | PAREKH RAJESH R | Director | Buy | P | 3.73 | 40,000 | 149,348 | 40,000 | 0 to 40 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 319 | 1,103 | 319 | 0 to 319 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 1,400 | 4,843 | 1,400 | 0 to 1.4 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 181 | 626 | 181 | 0 to 181 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 1,500 | 5,219 | 1,500 | 0 to 1.5 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 200 | 696 | 200 | 0 to 200 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 100 | 348 | 100 | 0 to 100 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 400 | 1,392 | 400 | 0 to 400 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 100 | 348 | 100 | 0 to 100 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.48 | 1,600 | 5,568 | 1,600 | 0 to 1.6 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.47 | 200 | 694 | 200 | 0 to 200 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 200 | 692 | 200 | 0 to 200 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 500 | 1,730 | 500 | 0 to 500 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.46 | 300 | 1,037 | 300 | 0 to 300 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.41 | 2,300 | 7,843 | 2,300 | 0 to 2.3 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.41 | 200 | 682 | 200 | 0 to 200 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Buy | P | 3.43 | 2,500 | 8,575 | 2,500 | 0 to 2.5 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Buy | P | 3.42 | 100 | 342 | 100 | 0 to 100 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Buy | P | 3.41 | 3,200 | 10,912 | 3,200 | 0 to 3.2 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Buy | P | 3.41 | 100 | 341 | 100 | 0 to 100 |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Buy | P | 3.41 | 1,600 | 5,454 | 1,600 | 0 to 1.6 K |
| Sep 13 2010 | AVAN | Celldex Therapeuti ... | SCHALLER CHARLES R | Director | Buy | P | 3.45 | 5,000 | 17,250 | 5,000 | 0 to 5 K |
| Sep 09 2010 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Buy | P | 3.49 | 3,000 | 10,470 | 3,000 | 0 to 3 K |
| Sep 09 2010 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 3.51 | 2,000 | 7,016 | 2,000 | 0 to 2 K |
| Jan 22 2010 | AVAN | Celldex Therapeuti ... | Davis Thomas Andrew | Sr. VP & CMO | Option Exercise | A | 4.50 | 95,000 | 427,500 | 95,000 | |
| Jan 22 2010 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Option Exercise | A | 4.50 | 90,000 | 405,000 | 90,000 | |
| Jan 22 2010 | AVAN | Celldex Therapeuti ... | KELER TIBOR | Sr. VP & CSO | Option Exercise | A | 4.50 | 90,000 | 405,000 | 90,000 | |
| Jan 22 2010 | AVAN | Celldex Therapeuti ... | Marucci Anthony S | President & CEO | Option Exercise | A | 4.50 | 164,000 | 738,000 | 164,000 | |
| Dec 28 2009 | AVAN | Celldex Therapeuti ... | CONRAD HERBERT J | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Option Exercise | A | 4.48 | 8,000 | 35,840 | 8,000 | |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | SHANNON TIMOTHY M | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | PAREKH RAJESH R | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | Elston George | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | SCHALLER CHARLES R | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | LIPTON KAREN SHOOS | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 24 2009 | AVAN | Celldex Therapeuti ... | PENNER HARRY JR | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Dec 03 2009 | AVAN | Celldex Therapeuti ... | SCHALLER CHARLES R | Director | Buy | P | 4.69 | 4,600 | 21,574 | 4,600 | 0 to 4.6 K |
| Dec 03 2009 | AVAN | Celldex Therapeuti ... | SCHALLER CHARLES R | Director | Buy | P | 4.68 | 2,400 | 11,232 | 2,400 | 0 to 2.4 K |
| Dec 01 2009 | AVAN | Celldex Therapeuti ... | CATLIN AVERY W | Sr. VP & CFO | Buy | P | 4.41 | 1,000 | 4,408 | 1,000 | 0 to 1,000 |
| Nov 30 2009 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 4.51 | 2,400 | 10,824 | 2,400 | 0 to 2.4 K |
| Nov 30 2009 | AVAN | Celldex Therapeuti ... | ELLBERGER LARRY | Director | Buy | P | 4.50 | 7,600 | 34,200 | 7,600 | 0 to 7.6 K |